Jonathan Aschoff
Stock Analyst at Roth MKM
(0.02)
# 4,569
Out of 4,574 analysts
437
Total ratings
30.6%
Success rate
-20.4%
Average return
Main Sectors:
Stocks Rated by Jonathan Aschoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZVRA Zevra Therapeutics | Maintained: Buy | $21 | $9.53 | +120.47% | 16 | Jul 24, 2026 | |
| CELZ Creative Medical Technology Holdings | Maintained: Buy | $20 | $0.8102 | +2,368.53% | 8 | Jul 6, 2026 | |
| NVCT Nuvectis Pharma | Rated: Buy | $20 → $33 | $19.31 | +70.90% | 3 | Jul 6, 2026 | |
| GOVX GeoVax Labs | Maintained: Buy | $10 | $0.7312 | +1,267.61% | 15 | May 26, 2026 | |
| BFRI Biofrontera | Maintained: Buy | $9 | $1.09 | +725.69% | 12 | May 15, 2026 | |
| PTHS Pelthos Therapeutics | Maintained: Buy | $55 | $25.92 | +112.19% | 5 | May 15, 2026 | |
| APVO Aptevo Therapeutics | Maintained: Buy | $21 | $4.39 | +378.36% | 10 | May 14, 2026 | |
| CLNN Clene | Maintained: Buy | $30 | $5.39 | +456.59% | 6 | May 14, 2026 | |
| REVB Revelation Biosciences | Maintained: Buy | $16 | $1.06 | +1,409.43% | 13 | May 8, 2026 | |
| MDCX Medicus Pharma | Maintained: Buy | $9 | $0.37 | +2,332.43% | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 → $11 | $2.41 | +356.43% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $15 | $0.29 | +5,072.41% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $3 | $0.3243 | +825.07% | 5 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $2.12 | +1,362.26% | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $3 | $0.000001 | n/a | 8 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $2 | $0.04 | n/a | 11 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $14.53 | n/a | 7 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $2.05 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | €2.96 | n/a | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.915 | n/a | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.60 | $0.09 | n/a | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 | $3.04 | n/a | 9 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $36 | $43.17 | n/a | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 → $24 | $1.63 | n/a | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $620 → $500 | $0.0111 | n/a | 3 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $8.52 | n/a | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.21 | n/a | 1 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $30 | $0.1831 | n/a | 3 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.08705 | n/a | 5 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $8 | $0.0001 | n/a | 5 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $0.00001 | n/a | 4 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $9.39 | n/a | 1 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $0.0001 | n/a | 3 | Nov 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $0.9701 | n/a | 17 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $11 | $2.51 | n/a | 3 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $26 | $1.62 | n/a | 2 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.8122 | n/a | 1 | Apr 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.011 | n/a | 8 | Sep 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.95 | n/a | 12 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $0.4558 | n/a | 17 | Sep 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $241.00 | n/a | 5 | Aug 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92 | $117.67 | n/a | 14 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.36 | n/a | 10 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $35.28 | n/a | 11 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3 | $6.63 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $56.04 | n/a | 21 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $1.22 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $3.73 | n/a | 6 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $25.88 | n/a | 16 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $70.73 | n/a | 13 | Aug 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.000001 | n/a | 10 | Jul 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $489 | $656.01 | n/a | 18 | Mar 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.3713 | n/a | 4 | Nov 12, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $0.9884 | n/a | 3 | Dec 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $59.33 | n/a | 3 | Oct 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $528.47 | n/a | 1 | Feb 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $1.51 | n/a | 1 | Jan 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.55 | n/a | 2 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $81.93 | n/a | 2 | Apr 16, 2012 |
Zevra Therapeutics
Jul 24, 2026
Maintained: Buy
Price Target: $21
Current: $9.53
Upside: +120.47%
Creative Medical Technology Holdings
Jul 6, 2026
Maintained: Buy
Price Target: $20
Current: $0.8102
Upside: +2,368.53%
Nuvectis Pharma
Jul 6, 2026
Rated: Buy
Price Target: $20 → $33
Current: $19.31
Upside: +70.90%
GeoVax Labs
May 26, 2026
Maintained: Buy
Price Target: $10
Current: $0.7312
Upside: +1,267.61%
Biofrontera
May 15, 2026
Maintained: Buy
Price Target: $9
Current: $1.09
Upside: +725.69%
Pelthos Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $55
Current: $25.92
Upside: +112.19%
Aptevo Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $21
Current: $4.39
Upside: +378.36%
Clene
May 14, 2026
Maintained: Buy
Price Target: $30
Current: $5.39
Upside: +456.59%
Revelation Biosciences
May 8, 2026
Maintained: Buy
Price Target: $16
Current: $1.06
Upside: +1,409.43%
Medicus Pharma
May 7, 2026
Maintained: Buy
Price Target: $9
Current: $0.37
Upside: +2,332.43%
May 5, 2026
Rated: Buy
Price Target: $14 → $11
Current: $2.41
Upside: +356.43%
Apr 2, 2026
Maintained: Buy
Price Target: $18 → $15
Current: $0.29
Upside: +5,072.41%
Mar 2, 2026
Maintained: Buy
Price Target: $8 → $3
Current: $0.3243
Upside: +825.07%
Feb 23, 2026
Maintained: Buy
Price Target: $31
Current: $2.12
Upside: +1,362.26%
Jul 8, 2025
Maintained: Buy
Price Target: $4 → $3
Current: $0.000001
Upside: n/a
Jun 4, 2025
Maintained: Buy
Price Target: $9 → $2
Current: $0.04
Upside: n/a
May 15, 2025
Maintained: Buy
Price Target: $30
Current: $14.53
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $13 → $11
Current: $2.05
Upside: n/a
May 12, 2025
Maintained: Buy
Price Target: €12.00
Current: €2.96
Upside: n/a
Oct 23, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.915
Upside: n/a
Sep 3, 2024
Maintained: Buy
Price Target: $0.60
Current: $0.09
Upside: n/a
May 21, 2024
Rated: Buy
Price Target: $36
Current: $3.04
Upside: n/a
Mar 7, 2024
Maintained: Buy
Price Target: $25 → $36
Current: $43.17
Upside: n/a
Mar 5, 2024
Maintained: Buy
Price Target: $250 → $24
Current: $1.63
Upside: n/a
Dec 18, 2023
Maintained: Buy
Price Target: $620 → $500
Current: $0.0111
Upside: n/a
Feb 27, 2023
Maintained: Buy
Price Target: $14
Current: $8.52
Upside: n/a
Jun 15, 2022
Initiated Coverage: Buy
Price Target: $8
Current: $1.21
Upside: n/a
Apr 28, 2022
Maintained: Buy
Price Target: $4 → $30
Current: $0.1831
Upside: n/a
Oct 25, 2021
Reiterated: Buy
Price Target: $24
Current: $0.08705
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $2.5 → $8
Current: $0.0001
Upside: n/a
Aug 30, 2021
Maintained: Buy
Price Target: $7
Current: $0.00001
Upside: n/a
Mar 11, 2021
Initiated Coverage: Buy
Price Target: $38
Current: $9.39
Upside: n/a
Nov 22, 2020
Maintained: Buy
Price Target: $18
Current: $0.0001
Upside: n/a
Nov 17, 2020
Downgraded: Sell
Price Target: $8
Current: $0.9701
Upside: n/a
Oct 14, 2020
Reiterated: Buy
Price Target: $14 → $11
Current: $2.51
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: $13 → $26
Current: $1.62
Upside: n/a
Apr 20, 2020
Reiterated: Buy
Price Target: $9
Current: $0.8122
Upside: n/a
Sep 15, 2016
Reiterated: Buy
Price Target: $14
Current: $0.011
Upside: n/a
Sep 13, 2016
Reiterated: Buy
Price Target: $4
Current: $1.95
Upside: n/a
Sep 9, 2016
Reiterated: Buy
Price Target: $55
Current: $0.4558
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $29
Current: $241.00
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $92
Current: $117.67
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $24
Current: $0.36
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $24 → $16
Current: $35.28
Upside: n/a
Aug 9, 2016
Reiterated: Sell
Price Target: $4 → $3
Current: $6.63
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $28
Current: $56.04
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $26
Current: $1.22
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $16
Current: $3.73
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: n/a
Current: $25.88
Upside: n/a
Aug 4, 2016
Reiterated: Buy
Price Target: $16 → $18
Current: $70.73
Upside: n/a
Jul 6, 2016
Reiterated: Buy
Price Target: $8
Current: $0.000001
Upside: n/a
Mar 8, 2016
Initiated Coverage: Buy
Price Target: $489
Current: $656.01
Upside: n/a
Nov 12, 2015
Reiterated: Buy
Price Target: $5
Current: $0.3713
Upside: n/a
Dec 8, 2014
Maintained: Buy
Price Target: $16
Current: $0.9884
Upside: n/a
Oct 24, 2014
Maintained: Hold
Price Target: n/a
Current: $59.33
Upside: n/a
Feb 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $528.47
Upside: n/a
Jan 17, 2013
Downgraded: Sell
Price Target: $1
Current: $1.51
Upside: n/a
Jun 29, 2012
Reiterated: Buy
Price Target: n/a
Current: $25.55
Upside: n/a
Apr 16, 2012
Maintained: Buy
Price Target: $13 → $11
Current: $81.93
Upside: n/a